We’re Here to Help

SNMMI's communications staff is available to handle your inquiries, arrange interviews with experts, provide copies of research articles and more.

For assistance, please contact Rebecca Maxey, director of communications, at rmaxey@snmmi.org or (703) 652-6772.


SNMMI is dedicated to being the premier source of information on nuclear medicine and molecular imaging. The society's online newsroom provides reporters with the information needed to write articles and gain background information on the many topics related to nuclear medicine, molecular imaging and therapy.

SNMMI issues press releases on new research, society updates and industry news for members of the press. Check back frequently to see what's new with SNMMI.

View press releases on the latest research and news from SNMMI.

Please see Tab 6 for information about SNMMI's 2024 Annual Meeting.

Nuclear and molecular imaging are vital elements of today's medical practice, adding an additional dimension to diagnosis that can change the way diseases are understood and treated. Nuclear medicine therapies treat specific diseases, such as lymphoma or thyroid cancer, by allowing a high dose of medicine to be delivered directly to a tumor or problem area. SNMMI's fact sheets explain how nuclear medicine and molecular imaging can help diagnose and/or treat a wide range of diseases.

Interested in radiopharmaceutical therapy for cancer and other diseases? Visit our Therapy Central portal, or check out our nuclear medicine therapy infographic


SNMMI publishes two peer-reviewed medical journals—The Journal of Nuclear Medicine (JNM) and The Journal of Nuclear Medicine Technology (JNMT)which feature the latest in molecular imaging research. JNM and JNMT are the most widely read peer-reviewed publications in molecular imaging, nuclear medicine and allied disciplines.

Every month, JNM brings readers around the globe key research articles on theranostics, nuclear medicine therapy, and imaging of cancer, neurological disease, cardiological disease, and other disease as well as continuing education articles and updates on rapidly changing issues in practice and research. 

Published quarterly, JNMT focuses on technology, quality assurance, radiation safety, and the clinical applications of nuclear medicine. Each issue features continuing education articles written by leading educators in nuclear medicine technology as well as news and updates on practice, licensure, and credentialing for nuclear medicine technologists. Practitioners from across the imaging sciences turn to JNMT for peer-reviewed information related to daily clinical practice.

SNMMI can connect you with subject-matter experts on a variety of topics who are ready to respond to tight deadlines. Contact Rebecca Maxey, director of communications, at rmaxey@snmmi.org or at (703) 652-6772, to set up an interview with SNMMI's leadership or with one of its many experts on oncology, brain disease, heart disease, radiopharmaceuticals, reimbursement and more.

SNMMI Leadership

  • Helen Nadel, MD, FRCPC, FSNMMI
    SNMMI President

  • Cathy Sue Cutler, PhD, FSNMMI
    SNMMI President-Elect

  • Jean-Luc C. Urbain, MD, PhD, CPE, FASNC
    SNMMI Vice President-Elect

SNMMI-TS Leadership

  • Dmitry D. Beyder, MPA, CNMT
    SNMMI-TS President

  • Julie Dawn Bolin, MS, CNMT
    SNMMI-TS President-Elect

Join SNMMI on our social media networks to stay updated on the latest from the society and the nuclear medicine and molecular imaging field.

Facebook Thumbnail Twitter LinkedIn YouTube Icon  

SNMMI 2024 Annual Meeting

The SNMMI Annual Meeting is recognized as the premier educational, scientific, research, and networking event in nuclear medicine and molecular imaging. The four-day event, which generally takes place each June, provides physicians, technologists, pharmacists, laboratory professionals, and scientists with an in-depth view of the latest research and development in the field and the clinic.

The SNMMI 2024 Annual Meeting will take place June 8–11, 2024, at Metro Toronto Convention Centre in Toronto, ON, Canada. 

Who’s attending?

Leading molecular imaging and nuclear medicine physicians, radiologists, cardiologists, pharmacists, scientists, lab professionals, and technologists, representing the world's top medical and academic institutions and centers. The 2023 Annual Meeting attracted nearly 8,000 registrants

Educational Program and Features

The 2024 Annual Meeting will feature an exceptional program highlighted by some of the hottest topics in nuclear medicine and molecular imaging, including the latest scientific research, an extensive exhibit hall, networking events, and more


Research to be presented in oral scientific sessions is embargoed until the presentation has ended. Posters are embargoed until the poster hall opens on Saturday, June 8, at 6 pm Eastern. 

How do press register?

SNMMI offers free registration to accredited members of the press or writers who supply an official letter of assignment from a publication or media outlet. Media registration provides access to all open educational sessions, the exhibit area, and the press room.

Pre-registration is required. Members of the media should register by contacting Rebecca Maxey at rmaxey@snmmi.org or (703) 652-6772.

Press Office information

The SNMMI Press Office is room 707. An SNMMI press liaison will be present to handle media requests.


Saturday, June 8 — 1:00−5:00 pm
Sunday, June 9 — 10:00 am−5:30 pm
Monday, June 10 — 10:00 am−5:30 pm
Tuesday, June 11 — 8:00 am−TBA

Join the Conversation!

Follow us on Twitter @SNM_MI for the latest updates from the meeting; our official hashtag is #SNMMI24.

Event details and program information will be available in early 2024 on the SNMMI website.

  • Jun 8, 2024 -  Jun 11, 2024 SNMMI 2024 Annual Meeting
    Metro Toronto Convention Centre
    Headquarter Hotel: Fairmont Royal York | Toronto | Canada

Featured Resources